MVM launches drug discovery firm

Life sciences investor MVM has acquired CeNeS Pharmaceuticals' drug discovery division as part of a broader £5m investment round.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this